Study Demonstrates Potential Broad-Spectrum Anti-Alphavirus Therapeutics
2 Articles
2 Articles
Study demonstrates potential broad-spectrum anti-alphavirus therapeutics
A recent collaborative study has identified two promising single-domain antibodies (sdAbs) that may offer a therapeutic option against multiple subtypes of Venezuelan equine encephalitis virus (VEEV). The researchers, from the U.S. Army Medical Research Institute of Infectious Diseases, National Institutes of Health's Vaccine Research Center, U.S. Naval Research Laboratory, and the Frederick National Laboratory for Cancer Research, have publishe…
USAMRIID Collective Study Demonstrates Potential Broad-Spectrum Anti-Alphavirus Therapeutics
A recent collaborative study between the U.S. Army Medical Research Institute of Infectious Diseases, National Institutes of Health’s Vaccine Research Center, U.S. Naval Research Laboratory, and the Frederick National Laboratory for Cancer Research has identified two promising single-domain antibodies (sdAbs) that may offer a therapeutic option against multiple subtypes of Venezuelan equine encephalitis virus (VEEV).
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


